Navigation Links
Survival of the rarest: Fruit flies shed light on the evolution of behavior

Sometimes, it pays to be rare—think of a one-of-a-kind diamond, a unique Picasso or the switch-hitter on a baseball team.

Now, new research suggests that being rare has biological benefits. Professor Marla Sokolowski, a biologist at the University of Toronto Mississauga who in the 1980s discovered that a single gene affects the foraging behaviour of fruit flies, has identified the benefit of rarity in populations of fruit flies with two different versions of the foraging gene. This gene is of particular interest because it is also found in many organisms, including humans. The new study appears in the May 10 issue of the journal Nature.

"There's considerable genetic variation in nature and we haven't been able to explain why it persists, since natural selection ensures that only the best survive," says Sokolowski, who holds a Canada Research Chair in Genetics. "In some cases, individuals with characteristics that differ from the rest of the population are more likely to survive since their rarity makes them less conspicuous to predators. However, to date we haven't understood this type of survival advantage at the level of the gene."

The findings involve a phenomenon known as "negative frequency-dependent selection." Essentially, it suggests that rare variants have a better chance of survival—just as a rare strain of the flu has a better chance of spreading through a population that is already immune to more common strains of the virus. In this case, flies carry one of two versions of the foraging gene (either the "rover" or "sitter" type). Rover larvae move around more than sitter larvae while feeding and they are also more likely to explore new food patches than sitters. The researchers explored the evolutionary mechanism that favours the persistence of both of these types in nature.

Doctoral student Mark Fitzpatrick raised colonies of flies with different ratios of rovers to sitters and different concentrations of nutrients i
'"/>

Source:University of Toronto


Page: 1 2

Related biology news :

1. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
2. Protein That Promotes Survival Of Stem Cells Might Be Key To Poor Leukemia Prognosis
3. Bevacizumab Combined With Chemotherapy Improves Progression-Free Survival for Patients With Advanced Breast Cancer
4. Survival of heart patients on beta-blockers varies greatly with genetic variation
5. Survival of the selfless - scientists find cheats dont always prosper
6. X-Ray Beams And Fruit Fly Flight Simulator Aid Scientists View Of Muscle Power
7. Fruit fly studies open new window on cancer research
8. Fruit fly research set to revolutionize study of birth defects
9. How Fruitflies Know Its Time for Lunch
10. Fruit flys beating heart helps identify human heart disease genes
11. Fruit fly reveals a potential connection between dementia and cancer

Post Your Comments:
(Date:12/1/2009)...unce the publication of results from its Phase II ...rability of its novel, intranasal drug/device prod...sitis with nasal polyps in Rhinology , the offici...logic Societies. , Chronic rhinosinusitis with ...cantly reduce a patient,s quality of life, causing...
(Date:12/1/2009)...researchers have developed a tumor-attacking viru... growth of new tumor blood vessels. , Their rese...lls oncolytic viruses might be more effective ag... gene for a protein that inhibits blood-vessel gro...ally produced in the brain. In this study, an onco...
(Date:12/1/2009)...rks can be solved with a new technique that identi...their victims, according to a University of Florid...logous to analyzing human fingerprints, scientists...hark bites to the jaws and teeth of the powerful p...ernational Shark Attack File, which is housed at U...
Breaking Biology News(10 mins):New data on highly effective treatment for chronic rhinosinusitis with nasal polyps 2Tumor-attacking virus strikes with 'one-two punch' 2New forensic technique gives clues about sharks from bite damage 2New forensic technique gives clues about sharks from bite damage 3Caraco Pharmaceutical Laboratories Ltd Markets Nicardipine Hydrochloride Injection 6376 1Caraco Pharmaceutical Laboratories Ltd Markets Nicardipine Hydrochloride Injection 6376 2Cancers sweet tooth may be weakness 10788 1Cancers sweet tooth may be weakness 10788 2HCA Names Joe Sowell Senior Vice President 26amp 3B Chief Development Officer 61620 1HCA Names Joe Sowell Senior Vice President 26amp 3B Chief Development Officer 61620 2
... Conn. A joint Yale-Peking University center that...erstanding of plant biology will receive five year...nto Company, a leading provider of agricultural te...es and a series of plant biology-related programs ...olecular Genetics and Agrobiotechnology , a multid...
...computers to compare portions of the human genome ...l have discovered some 300 previously unidentified...red genes already known., The discovery is based o...enetic code that do something useful for the organ...orted by Adam Siepel, Cornell assistant professor ...
...rne diseases such as malaria and dengue cause suff...auses at least one million deaths annually, and is...e of five. In addition to the human toll, these d...y communities that can least afford it. Various a...secticides, vaccine development, and preventive me...
Other Biology News:Monsanto expands sponsorship for Peking-Yale Joint Agrobiotechnology Center 2Evolutionary comparison finds new human genes 2Evolutionary comparison finds new human genes 3Selfish DNA and the Genetic Control of Vector-Borne Diseases 2Selfish DNA and the Genetic Control of Vector-Borne Diseases 3
(Date:12/1/2009)...c. 1 Reportlinker.com announces th...s catalogue: ,, Emerging Clinical Trial Locati...ging healthcare and regulatory environment ,, ...nical-Trial-Locations---Eastern-Europe-Market-dyna...vironment.html ,, Over the last decade pharmac...
(Date:12/1/2009)...ty Leader Richard Gephardt Brings Together A-List ...nities for "Best and Brightest Forum on Medical I...wswire-USNewswire/ -- Several of New Jersey,s most..., medicine and technology gathered today at the Li...medical innovation in New Jersey, and throughout t...
(Date:12/1/2009)...l., Dec. 1 Prairie Heart Institute...was recently awarded two statuettes at the first-e... York City. The CLIO Healthcare Awards recognizes ...re advertising industry and is an extension of the...wards competitions for advertising, design and int...
(Date:12/1/2009)...ax, Inc. today announced a collaborative research ...aimed at evaluating EpiVax’s proprietary Tre...detrimental immune responses to certain drugs. In ...EpiVax Tregitope technology will be evaluated for ...apeutics. , (Vocus) Decem...
Breaking Biology Technology:Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 2Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 3Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 4Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 5Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 6Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 7Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 8New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 2New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 3New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 4New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 5Prairie Heart Institute of Illinois Wins Two CLIO Healthcare Awards 2EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 2EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 3
... 2009 Senomyx, Inc. (Nasdaq: SNMX ) will releas... fiscal year ending December 31, 2008 on Thursday,...financial markets. The Company will also host a c...0 a.m. Eastern Time (8:00 a.m. Pacific Time) that ...ill provide a business update and will discuss the...
...o help eye specialists better understand the impac...eir patients, Viscira teamed up with an industry-l...a virtual experience of having neovascular (wet) a... San Francisco, CA (PRWEB) January ...and the impact of one of the fastest growing eye d...
...exsun Corp, a leader in renewable energy and biofu...e appointment of David Pyrce as its Chief Executiv... Los Angeles (PRWEB) Janua...energy and biofuels development and production, to...s Chief Executive Officer and member of the Board ...
Other Biology Technology:SENOMYX, INC. fourth quarter AND FISCAL YEAR-END 2008 Earnings conference call scheduled for February 12, 2009 2Looking at AMD Through Patients' Eyes: Viscira Virtual Exhibit Educates Physicians by Personalizing Serious Eye Disease 2Looking at AMD Through Patients' Eyes: Viscira Virtual Exhibit Educates Physicians by Personalizing Serious Eye Disease 3Nexsun Corp Names Industry Executive David Pyrce as Chief Executive Officer 2
Mouse Anti-Kusabira Orange Monoclonal Antibody, Unconjugated, Clone 2G9 from MBL International
Goat Anti-SPFH2 Polyclonal Antibody, Unconjugated from Abcam
Goat Anti-Als2 Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-Kusabira Orange Monoclonal Antibody, Unconjugated, Clone 2G9 from MBL International
Biology Products: